In a significant public health alert, the Central Drugs Standard Control Organisation (CDSCO) has identified 50 commonly used medications, including those for fever, blood pressure, diabetes, and acid reflux, as substandard. These medicines, relied on by millions of patients across India, were found to have impurities, inadequate active ingredients, or other quality deficiencies.
The revelation emerged from routine quality checks conducted by the CDSCO, aimed at ensuring the safety and efficacy of drugs sold in the country. The substandard findings have raised concerns about patient health, especially for those managing chronic conditions.
Health experts are advising patients to consult their doctors and explore alternative treatments where necessary. Meanwhile, the CDSCO has ordered the recall of affected batches and launched further investigations into the causes of the quality lapses. The incident highlights the urgent need for stricter regulatory oversight in India’s pharmaceutical industry to protect consumer safety and maintain trust in essential medications.
